Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Veritas In Silico Inc. ( (JP:130A) ) has provided an update.
Veritas In Silico Inc. announced the relocation of its Shin-Kawasaki Research Institute to a new facility in Kawasaki City, scheduled for mid-March 2026. This move aims to support the company’s growing research initiatives and infrastructure expansion. The relocation costs have been accounted for in the current financial forecast, and the company anticipates no significant impact on its financial position or business results.
More about Veritas In Silico Inc.
Veritas In Silico Inc. operates in the biotechnology industry, focusing on drug discovery and development. The company is enhancing its research capabilities by expanding AI technology, increasing its team of researchers, and upgrading its research equipment.
Average Trading Volume: 274,536
Technical Sentiment Signal: Hold
Current Market Cap: Yen4.67B
See more insights into 130A stock on TipRanks’ Stock Analysis page.